Immunosuppression by breast cancer associated p43-effect of immunomodulators
- 1 June 1996
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 41 (2) , 171-176
- https://doi.org/10.1007/bf01807162
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Alterations of cell surface antigens induced by placental isoform of ferritin in human carcinoma cell linesCancer Letters, 1995
- Downregulation of lymphocyte mitogenesis by breast cancer-associated p43Cancer Letters, 1994
- Immunohistochemical and Biochemical Measurement of Estrogen and Progesterone Receptors in Primary Breast Cancer Correlation of Histopathology and Prognostic FactorsAnnals of Surgery, 1993
- Determination of placental ferritin (PLF)-positive lymphocytes in women in early stages of breast cancerInternational Journal of Cancer, 1992
- Placental isoferritin associated p43 antigen correlates with features of high differentiation in breast cancerBreast Cancer Research and Treatment, 1992
- Accessory Cell-Dependent T-Cell Activation via Ti-CD3.Scandinavian Journal of Immunology, 1988
- Activation of Resting, Pure CD4+, and CD8+ Cells via CD3.Scandinavian Journal of Immunology, 1987
- Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligandNature, 1987
- INHIBITORY EFFECTS OF ISOFERRITINS FROM TUMOUR AND NON-TUMOUR TISSUES ON E-ROSETTE FORMATIONThe Lancet, 1984
- Elimination of Allogeneic Lymphocytes by MiceImmunological Reviews, 1983